Next Article in Journal
Evaluation of Adjuvant Treatments for Adenoid Cystic Carcinoma of the Breast: A Population-Based, Propensity Score Matched Cohort Study from the SEER Database
Next Article in Special Issue
HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions
Previous Article in Journal
Unexpected Movement of the Esophagus across the Aorta
Previous Article in Special Issue
“Modified Schirmer Test” as an Objective Measurement for Vaginal Dryness: A Prospective Cohort Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review

1
Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy
2
Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Medicine, University of Sassari, 07100 Sassari, Italy
3
Department of Biomedical Science, University of Sassari, 07100 Sassari, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Diagnostics 2022, 12(7), 1759; https://doi.org/10.3390/diagnostics12071759
Submission received: 1 June 2022 / Revised: 15 July 2022 / Accepted: 18 July 2022 / Published: 20 July 2022
(This article belongs to the Special Issue Diagnosis of Lower Genital Tract Disease)

Abstract

The etiology of bladder cancer is known to be associated with behavioral and environmental factors. Moreover, several studies suggested a potential role of HPV infection in the pathogenesis with controversial results. A systematic review was conducted to assess the role of HPV. A total of 46 articles that reported the prevalence of HPV infection in squamous (SCC), urothelial (UC), and transitional cell carcinomas (TCC) were selected. A pooled prevalence of 19% was found, with a significant difference in SCC that was mainly driven by HPV-16. Moreover, infection prevalence in case-control studies showed a higher risk of bladder cancer in HPV-positive cases (OR: 7.84; p-value < 0.00001). The results may suggest an etiologic role of HPV in bladder cancer. HPV vaccine administration in both sexes could be key to prevent the infection caused by high-risk genotypes.
Keywords: human papillomavirus; HPV; bladder cancer; HPV detection; urothelial carcinoma; transitional cell carcinoma human papillomavirus; HPV; bladder cancer; HPV detection; urothelial carcinoma; transitional cell carcinoma

Share and Cite

MDPI and ACS Style

Muresu, N.; Di Lorenzo, B.; Saderi, L.; Sechi, I.; Del Rio, A.; Piana, A.; Sotgiu, G. Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review. Diagnostics 2022, 12, 1759. https://doi.org/10.3390/diagnostics12071759

AMA Style

Muresu N, Di Lorenzo B, Saderi L, Sechi I, Del Rio A, Piana A, Sotgiu G. Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review. Diagnostics. 2022; 12(7):1759. https://doi.org/10.3390/diagnostics12071759

Chicago/Turabian Style

Muresu, Narcisa, Biagio Di Lorenzo, Laura Saderi, Illari Sechi, Arcadia Del Rio, Andrea Piana, and Giovanni Sotgiu. 2022. "Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review" Diagnostics 12, no. 7: 1759. https://doi.org/10.3390/diagnostics12071759

APA Style

Muresu, N., Di Lorenzo, B., Saderi, L., Sechi, I., Del Rio, A., Piana, A., & Sotgiu, G. (2022). Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review. Diagnostics, 12(7), 1759. https://doi.org/10.3390/diagnostics12071759

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop